查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529702

內視鏡逆行性造影市場規模、佔有率、趨勢分析報告：按產品、手術、最終用途、地區和細分市場預測，2024-2030 年

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product, By Procedure, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

市場規模及趨勢

預計2023年全球內視鏡逆行性造影市場規模為19.8億美元，預估2024年至2030年複合年成長率為8.3%。這種成長主要是由於膽結石、胰臟炎和膽管阻塞等胰臟和膽道疾病的盛行率不斷增加，刺激了對內視鏡逆行性造影（ERCP）手術的需求。隨著人口老化和生活方式的改變，這些疾病的盛行率預計將增加，從而推動市場成長。根據 2024 年 2 月發表的臨床胃腸病學和肝病學研究，全球整體膽結石的盛行率估計為 6%，其中女性和南美洲的盛行率更高。根據研究，膽結石的盛行率預計在預測期內將急劇上升，從而推動對 ERCP 手術的需求。

此外，內視鏡技術的進步提高了 ERCP 手術的安全性和有效性。例如，2023年1月，研華推出了MIO-5377R單板電腦，作為內視鏡技術領域的突破性創新。這款小巧強大的裝置旨在解決內視鏡面臨的傳統挑戰，提高性能、可靠性和功能。此外，高清成像、內視鏡可操作性的提高以及治療配件的開發等技術創新使ERCP成為更精準、有效的診斷和治療工具。這些技術進步促使醫療保健提供者和患者選擇 ERCP 手術。

微創手術技術的日益普及增加了對 ERCP 手術的需求，預計將在未來幾年推動產業成長。例如，根據美國癌症協會2024年1月發布的年度報告，美國預計將新增41,630例肝癌確診病例。此外，根據同一資訊來源，肝癌在東南亞次南亞和撒哈拉非洲國家比在美國更常見。此外，肝癌是全球癌症相關死亡的主要原因，每年奪走超過 70 萬人的生命。

鑑於膽管癌和肝細胞癌的沉重負擔，用於早期發現這些惡性的內視鏡逆行性造影的需求預計將會增加。

此外，人們越來越認知到早期診斷和治療胰臟和膽道疾病的好處，導致對 ERCP 等微創手術的需求增加。例如，2023 年 10 月，膽道閉鎖意識委員會在豪登省固態器官移植中心和威特沃特斯蘭德大學夏洛特馬克塞基學術醫院的贊助下發起了膽道閉鎖意識宣傳活動。該宣傳活動旨在意識提升和支持，膽道閉鎖是一種罕見且危及生命的肝臟疾病，由於膽管阻塞或消失而影響嬰幼兒和幼兒。該舉措的重點是對不同人群進行有關膽道閉鎖的教育，為受影響的家庭提供研究和支持，促進診斷工具和治療方法的研究，並促進與全球衛生組織的合作。

人口老化是推動ERCP市場成長的關鍵因素。隨著世界人口老化，對這些手術（包括需要輸血的手術）的需求正在增加。隨著成年人口的成長，尾靜脈疾病、貧血和手術抽血等慢性疾病呈現上升趨勢。目前光在美國就有超過 4,000 萬人年齡在 65 歲以上，預計到 2050 年這一數字將增加一倍。日本擁有世界上最多的老年人口，為該市場提供了潛在的成長機會。根據世界衛生組織預測，2050年，老年人口比例預計將達到22.0%。

此外，一些醫療機構正在採取涉及創新產品研發合作的舉措，刺激市場成長。例如，在2022年7月發表在Optica出版集團的研究中，生物醫學工程與成像科學學院的研究人員開發了一種光聲成像內視鏡探頭，可以插入內徑為0.6毫米的醫用針中。他也提出了利用人工智慧（AI）加速影像診斷的可能性。

此外，市場參與企業採取的策略性舉措（例如併購和產品發布）預計將在預測期內推動市場發展。例如，2022年4月，Olympus與專注於止血領域技術開發的公司EndoClot Plus合作。 EndoClot Plus 的主要產品之一是 EndoClot PHS，這是一種非熱、非創傷性的止消化道出血方法。該協議旨在讓胃腸病學家更容易使用 Endoclot PHS，使他們能夠在醫療過程中快速、可靠地止血。

全球內視鏡逆行性造影市場報告細分

該報告預測了全球、區域和國家層面的收益成長，並對2018年至2030年各子區隔的最新行業趨勢進行了分析。在這項研究中，Grand View Research, Inc. 根據產品、手術、最終用途和地區對全球內視鏡逆行性造影市場報告進行了細分。

目錄

第1章調查方法和範圍

第2章執行概述

第3章經內視鏡逆行性膽胰管攝影術市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 經內視鏡逆行性膽胰管攝影術市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章經內視鏡逆行性膽胰管攝影術市場：產品、估計與趨勢分析

  • 細分儀表板
  • 經內視鏡逆行性膽胰管攝影術市場：產品波動分析
  • 按產品分類的經內視鏡逆行性膽胰管攝影術市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 內視鏡
  • 內視鏡治療裝置
  • 視覺化系統
  • 能源裝置
  • 其他

第5章經內視鏡逆行性膽胰管攝影術市場：程序、估計與趨勢分析

  • 細分儀表板
  • 經內視鏡逆行性膽胰管攝影術市場：手術變異分析
  • 經內視鏡逆行性膽胰管攝影術依手術方式的市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 膽管括約肌切開術
  • 膽管支架
  • 膽管擴大
  • 胰臟括約肌切開術
  • 胰管支架置入術
  • 胰管擴大

第6章經內視鏡逆行性膽胰管攝影術市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 經內視鏡逆行性膽胰管攝影術市場：最終用途變化分析
  • 依最終用途經內視鏡逆行性膽胰管攝影術市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 門診設施

第7章經內視鏡逆行性膽胰管攝影術市場：區域估計與趨勢分析

  • 區域儀表板
  • 經內視鏡逆行性膽胰管攝影術市場區域波動分析
  • 經內視鏡逆行性膽胰管攝影術市場：依技術和最終用途的區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 2018-2030年北美內經內視鏡逆行性膽胰管攝影術市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 2018-2030年歐洲內經內視鏡逆行性膽胰管攝影術市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區內經內視鏡逆行性膽胰管攝影術市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年拉丁美洲經內視鏡逆行性膽胰管攝影術市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲經內視鏡逆行性膽胰管攝影術市場估計與預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Olympus Corporation
    • CONMED Corporation
    • Boston Scientific Corporation
    • Medtronic PLC
    • Telemed System, Inc.
    • AMBU, Inc.
    • FUJIFILM Holdings Corporation
    • Hobbs Medical, Inc.
    • Cook Group
    • Streis PLC
    • HOYA Group
    • Karl Storz SE &Co. KG
Product Code: GVR-4-68040-327-5

Market Size & Trends

The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 1.98 billion in 2023 and is anticipated to grow at a CAGR of 8.3% from 2024 to 2030. This growth is majorly driven by the rising incidence of pancreatic and biliary diseases such as gallstones, pancreatitis, and bile duct obstructions fueling the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. According to the Clinical Gastroenterology and Hepatology study published in February 2024, there is an estimated 6% prevalence of gallstones globally, with higher rates observed in females and South America. According to studies, the incidence rate of gallstones is anticipated to rise sharply over the forecast period, thereby driving the demand for ERCP procedures.

Furthermore, advancements in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single-board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. Additionally, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Additionally, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

The high burden of cholangiocarcinoma and hepatocellular carcinoma is expected to boost the demand for endoscopic retrograde cholangiopancreatography for the early detection of such malignancies.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023. the Biliary Atresia Awareness Committee launched Biliary Atresia Awareness Campaign under the auspices of Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia, a rare and life-threatening liver disease that affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

The aging population is a significant factor driving the growth of the ERCP market. As the global population continues to age, there is a growing demand for these procedures, including surgeries that require blood transfusions. Chronic diseases such as caugulopathy, anemia, and surgical blood seeking continue to increase along with the increase in adult population. Currently, there are over 40 million people in the U.S. alone above 65 years and the number are expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the globe. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050.

Additionally, several healthcare organizations are adopting initiatives including partnerships for the R&D of innovative products, thereby fueling the market growth. For instance, according to research study published in Optica Publishing Group journal in July 2022, researchers at the School of Biomedical Engineering & Imaging Sciences developed a photoacoustic imaging endoscope probe which can be inserted into a medical needle with an inner diameter as small as 0.6 millimeters. They also suggested that artificial intelligence (AI) could be utilized to accelerate imaging procedures.

Furthermore, the strategic initiatives adopted by the market players, such as mergers, and acquisitions, and product launches are projected to drive the market over the forecast period. For instance, in April 2022, Olympus partnered with EndoClot Plus, a company that focuses on developing technologies in the hemostasis space. One of the key products in EndoClot Plus' portfolio is the EndoClot PHS, a nonthermal, nontraumatic method for achieving hemostasis with gastrointestinal (GI) bleeds. This agreement aims to make the EndoClot PHS more accessible to gastroenterologists, enabling them to stop bleeding rapidly and reliably during medical procedures.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Endoscopes
  • Endotherapy Devices

Sphincterotomes

Lithotripter

Stents

Cannulas

Forceps

Snares

Catheters

Guiding Wires

Balloons

Baskets

  • Visualization Systems
  • Energy Devices
  • Others
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilation
  • End use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Procedure
    • 1.2.3. End use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Endoscopic Retrograde Cholangiopancreatography Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Endoscopic Retrograde Cholangiopancreatography Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Endoscopic Retrograde Cholangiopancreatography Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Endoscopic Retrograde Cholangiopancreatography Market: Product Movement Analysis
  • 4.3. Endoscopic Retrograde Cholangiopancreatography Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Endoscopes
    • 4.5.1. Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Endotherapy Devices
    • 4.6.1. Endotherapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Sphincterotomes
      • 4.6.2.1. Sphincterotomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Lithotripter
      • 4.6.3.1. Lithotripter Market Revenue Estimates and Fo recasts, 2018 - 2030 (USD Million)
    • 4.6.4. Stents
      • 4.6.4.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Cannulas
      • 4.6.5.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Forceps
      • 4.6.6.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.7. Snares
      • 4.6.7.1. Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.8. Catheters
      • 4.6.8.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.9. Guiding Wires
      • 4.6.9.1. Guiding Wires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.10. Balloons
      • 4.6.10.1. Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.11. Baskets
      • 4.6.11.1. Baskets Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Visualization Systems
    • 4.7.1. Visualization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Energy Devices
    • 4.8.1. Energy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Movement Analysis
  • 5.3. Endoscopic Retrograde Cholangiopancreatography Market by Procedure Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Biliary Sphincterotomy
    • 5.5.1. Biliary Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Biliary Stenting
    • 5.6.1. Biliary Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Biliary Dilatation
    • 5.7.1. Biliary Dilatation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Pancreatic Sphincterotomy
    • 5.8.1. Pancreatic Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Pancreatic Duct Stenting
    • 5.9.1. Pancreatic Duct Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Pancreatic Duct Dilation
    • 5.10.1. Pancreatic Duct Dilation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Endoscopic Retrograde Cholangiopancreatography Market: End use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Endoscopic Retrograde Cholangiopancreatography Market: End use Movement Analysis
  • 6.3. Endoscopic Retrograde Cholangiopancreatography Market by End use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Outpatient Facilities
    • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Endoscopic Retrograde Cholangiopancreatography Market movement analysis
  • 7.3. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis by Technology & End use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Olympus Corporation
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. CONMED Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Boston Scientific Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Medtronic PLC
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Telemed System, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. AMBU, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. FUJIFILM Holdings Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Hobbs Medical, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Cook Group
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Streis PLC
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. HOYA Group
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Karl Storz SE & Co. KG
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 5 Global Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America Endoscopic Retrograde Cholangiopancreatography market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 9 North America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 12 U.S. Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 15 Mexico Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million
  • Table 16 Canada Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 18 Canada Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 22 Europe Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 25 UK Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 28 Germany Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 31 France Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 34 Italy Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 37 Spain Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 40 Norway Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 43 Sweden Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 46 Denmark Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 53 Japan Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 55 China Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 56 China Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 59 India Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 62 Australia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 65 South Korea Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 68 Thailand Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 72 Latin America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 75 Brazil Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 78 Argentina Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 85 South Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 91 UAE Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Endoscopic Retrograde Cholangiopancreatography market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Endoscopic Retrograde Cholangiopancreatography market, product outlook key takeaways (USD Million)
  • Fig. 12 Endoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Endotherapy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Sphincterotomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Lithotripter market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Cannulas market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Forceps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Snares market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Guiding wires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Balloons market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Baskets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Visualization systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Energy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Endoscopic Retrograde Cholangiopancreatography market, Procedure outlook key takeaways (USD Million)
  • Fig. 28 Endoscopic Retrograde Cholangiopancreatography market: Procedure movement analysis 2023 & 2030 (USD Million)
  • Fig. 29 Biliary sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Biliary stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Biliary dilatation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Pancreatic sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pancreatic duct stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Pancreatic duct dilation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Endoscopic Retrograde Cholangiopancreatography market, end use outlook key takeaways (USD Million)
  • Fig. 36 Endoscopic Retrograde Cholangiopancreatography market: end use movement analysis 2023 & 2030 (USD Million)
  • Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Endoscopic Retrograde Cholangiopancreatography market: Regional key takeaways (USD Million)
  • Fig. 40 Endoscopic Retrograde Cholangiopancreatography market: regional outlook, 2023 & 2030, USD Million
  • Fig. 41 North America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 List of key emerging company's/technology disruptors/innovators